Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Sejahteraraya Anugrahjaya TbkISX:SRAJ 63 EBITDA Margin % is 2.70% as of Mar. 2026, which is 62% below its 10-year median of 7.05. GuruFocus rates ISX:SRAJ with a GF Score™ of 63/100 and a GF Value™ of Rp2,684.15 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 663 Healthcare Providers & Services companies, PT Sejahteraraya Anugrahjaya Tbk ranks worse than 57.62% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
PT Sejahteraraya Anugrahjaya Tbk EBITDA Margin % Related Terms
PT Sejahteraraya Anugrahjaya Tbk EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:SRAJ vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, PT Sejahteraraya Anugrahjaya Tbk's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Sejahteraraya Anugrahjaya Tbk EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Sejahteraraya Anugrahjaya Tbk's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where PT Sejahteraraya Anugrahjaya Tbk's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Sejahteraraya Anugrahjaya Tbk (ISX:SRAJ) has a EBITDA Margin % of 2.70% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Sejahteraraya Anugrahjaya Tbk and its competitors. This is 62% below median its historical median of 7.05. According to the industry distribution chart, PT Sejahteraraya Anugrahjaya Tbk ranks #382 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 57.6%.
Is PT Sejahteraraya Anugrahjaya Tbk's EBITDA Margin % too high?
PT Sejahteraraya Anugrahjaya Tbk's current EBITDA Margin % of 2.70% is 62% below median its 10-year median of 7.05. The Healthcare Providers & Services industry median EBITDA Margin % is 10.23. PT Sejahteraraya Anugrahjaya Tbk's value of 2.70% is 73.6% below this industry median. Based on the distribution chart, PT Sejahteraraya Anugrahjaya Tbk ranks #382 out of 663 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Sejahteraraya Anugrahjaya Tbk has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Sejahteraraya Anugrahjaya Tbk's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Sejahteraraya Anugrahjaya Tbk ranks #382 out of 663 companies for EBITDA Margin %. This places PT Sejahteraraya Anugrahjaya Tbk in the lower half of its industry. The industry median EBITDA Margin % is 10.23. PT Sejahteraraya Anugrahjaya Tbk's value of 2.70% is 73.6% below this benchmark. While the company's 10-year median is 7.05 vs. the industry median of 10.23, PT Sejahteraraya Anugrahjaya Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.23, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Sejahteraraya Anugrahjaya Tbk's current EBITDA Margin % of 2.70% is 73.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Sejahteraraya Anugrahjaya Tbk and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Sejahteraraya Anugrahjaya Tbk's current EBITDA Margin % is 2.70%, which is 62% below median its own 10-year median of 7.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Sejahteraraya Anugrahjaya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Sejahteraraya Anugrahjaya Tbk (ISX:SRAJ) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp2,684.15, compared to a current price of Rp11,000.00 — trading 309.8% above its estimated fair value. The current EBITDA Margin % is 2.70%, which is 62% below median its 10-year median of 7.05 and 73.6% below the Healthcare Providers & Services industry median of 10.23. PT Sejahteraraya Anugrahjaya Tbk's overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PT Sejahteraraya Anugrahjaya Tbk (ISX:SRAJ), the current EBITDA Margin % is 2.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Sejahteraraya Anugrahjaya Tbk (ISX:SRAJ) Overvalued in 2026?
Based on GuruFocus' analysis, PT Sejahteraraya Anugrahjaya Tbk stock appears to be overvalued.
The current stock price of Rp11,000.00 is trading 309.8% above its estimated GF Value™ of Rp2,684.15.
GuruFocus considers PT Sejahteraraya Anugrahjaya Tbk to be Significantly Overvalued.
Key valuation signals for ISX:SRAJ:
EBITDA Margin %: 2.70% (62% below median its 10-year median of 7.05)
GF Value™: Rp2,684.15 vs. price of Rp11,000.00 (309.8% above fair value)
Industry Position: 73.6% below the Healthcare Providers & Services median (#382 of 663)
No single metric tells the full story. See the ISX:SRAJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Sejahteraraya Anugrahjaya Tbk Business Description
PT Sejahteraraya Anugrahjaya Tbk operates hospitals and offers health care services. The company provides healthcare services encompassing medical services, supporting medical services, outpatient care, inpatient care, and emergency services. In addition, the company also delivers hospital management and operational services. It classifies its revenues into two main business activities, namely inpatient services and outpatient services. The majority of revenue is derived from the inpatient services business. The company is divided into four geographical areas: namely DKI Jakarta, Banten, West Java, and East Java.
63GF Score
Get the complete analysis for ISX:SRAJ
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SRAJ has been successfully added to your 
